/PRNewswire/ VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA.
Conroe, TX (PRWEB) April 27, 2023 VGXI Inc., a leading contract development and manufacturing organization (CDMO) for plasmid DNA, is pleased to announce
Conroe, TX (PRWEB) October 10, 2022 VGXI, Inc., a specialized contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene
Conroe, TX (PRWEB) August 17, 2022 VGXI, Inc., an industry-leading contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including